Related Experiment Video
Updated: Feb 25, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Pediatric HIV care and treatment services in Tanzania: implications for survival
G Somi1, M Majigo2, J Manyahi2
1National AIDS Control Programme, Ministry of Health, Community Development, Gender, Elderly and Children, Mwanza, Tanzania.
Insights
Improving child survival for HIV-infected children in Tanzania is crucial. Early Antiretroviral Therapy (ART) initiation significantly boosts survival rates, though challenges like late diagnosis and lost to follow-up persist.
Area of Science:
- Public Health
- Infectious Diseases
- Pediatrics
Background:
- Child survival for HIV-infected children is a global health priority.
- Tanzania has made progress in providing HIV care and treatment services to children.
Purpose of the Study:
- To assess the progress of HIV care and treatment services for children in Tanzania.
- To analyze enrollment, ART initiation, nutritional status, and mortality rates.
Main Methods:
- Utilized the National AIDS Control Programme Care and Treatment (CTC 2) database.
- Included children aged 0-14 years enrolled between January 2011 and December 2014.
- Assessed ART eligibility, time to ART initiation, nutritional status, and mortality using Kaplan-Meier methods.
Main Results:
- 29,531 ART-naive children were enrolled; 72% were eligible for ART at enrollment.
- Mortality probability increased with age, highest in very young children (<2 years).
- Children on ART showed 10-15% higher survival rates over time.
Conclusions:
- Significant progress in pediatric HIV care in Tanzania, with ~7000 children enrolled annually.
- Early ART initiation is key to improving survival, especially for children under 2 years.
- Challenges include advanced disease at enrollment, limited CD4 testing, and high loss to follow-up (31%).
Background:
Improving child survival for HIV-infected children remains an important health agenda. We present progress regarding care and treatment services to HIV infected children in Tanzania.
Methods:
The National AIDS Control Programme Care and Treatment (CTC 2) database was used to obtain information of all children aged 0-14yearsenrolled in the HIV Care and Treatment Program between January 2011 and December 2014. We assessed eligibility for ART, time from enrolment to ART initiation, nutritional status, and mortality using Kaplan-Meier methods.
Results:
A total of 29,531 (14,304 boys and 15,227 girls) ART-naive children aged 0-14 years were enrolled during the period, approximately 6700 to 8000 children per year. The male to female ratio was 48:50. At enrolment 72% were eligible for ART, 2-3% of children were positive for TB, and 2-4% were severely malnourished. Between 2011 and 2014, 2368 (8%) died, 9243 (31%) were Lost to Follow-up and 17,920 (61%) were on care or ART. The probability of death was 31% (95% CI 26-35), 43% (40-47), 52% (49-55) and 61% (58-64) by 1,2, 5 and 10 years of age, respectively. The hazard of death was greatest at very young ages (<2 years old), and decreased sharply by 4 years old. Children who were on ART had around 10-15% higher survival over time.
Conclusions:
Significant progress has been made regarding provision of paediatric HIV care and treatment in Tanzania. On average 7000 children are enrolled annually, and that approximately two thirds of children diagnosed under the age of 2 years were initiated on ART within a month. Provision of ART as soon as the child is diagnosed is the biggest factor in improving survival. However we noted that i) most children had advanced disease at the time of enrolment ii) approximately two-thirds of children were missing a baseline CD4 measurement and only 35% of children had either a CD4 count or percentage recorded, indicating limited access to CD4 testing services, and iii) 31% were lost to follow-up (LTFU). These challenges need to be addressed to improve early detection, enrolment and retention of HIV-infected children into care and improve documentation of services offered.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Excretion
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

